Mohammed Majrashi
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 4
- Advancements in Transdermal Drug Delivery 3
- Geriatrics and Gerontology top 10%
- Biomaterials top 10%
- Toxicology top 10%
-
- Cancer-related cognitive impairment studies 6
-
- Alzheimer's disease research and treatments 5
-
- Glioma Diagnosis and Treatment 3
-
- Neuroscience and Neuropharmacology Research 3
-
- Prenatal Substance Exposure Effects 3
- Co-authors
- Muralikrishnan DhanasekaranSindhu RameshManoj GovindarajuluVishnu SuppiramaniamTimothy MooreDwipayan BhattacharyaRajesh AminMohammed Alissa
- Partner nations
- Saudi ArabiaUnited StatesEgypt
In The Last Decade
Mohammed Majrashi
43 papers receiving 634 citations
Peers
Comparison fields: 5 of 111
- Pharmaceutical Science 54
- Geriatrics and Gerontology 34
- Biomaterials 103
- Toxicology 24
- Complementary and alternative medicine 51
Countries citing papers authored by Mohammed Majrashi
This map shows the geographic impact of Mohammed Majrashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Majrashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Majrashi more than expected).
Fields of papers citing papers by Mohammed Majrashi
This network shows the impact of papers produced by Mohammed Majrashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Majrashi. The network helps show where Mohammed Majrashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed Majrashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 15 | |
| 5 | 2023 | 23 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 64 | |
| 12 | 2022 | 17 | |
| 13 | 2021 | 8 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 68 | |
| 17 | 2018 | 14 | |
| 18 | 2018 | 68 | |
| 19 | 2017 | 12 | |
| 20 | Designer drug- Trifluoromethylphenylpiperazine derivatives (TFMPP) - A future potential peril towards modern society | 2017 | 1 |
About Mohammed Majrashi
Mohammed Majrashi is a scholar working on Microbiology, Pharmaceutical Science and Toxicology, having authored 47 papers that have together received 647 indexed citations. Recurring topics across this work include Cancer-related cognitive impairment studies (6 papers), Advanced Drug Delivery Systems (5 papers), Alzheimer's disease research and treatments (5 papers), Drug Solubulity and Delivery Systems (4 papers), Glioma Diagnosis and Treatment (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Prenatal Substance Exposure Effects (3 papers). The work is most often cited by research in Pharmaceutical Science (54 citations), Geriatrics and Gerontology (34 citations) and Biomaterials (103 citations). Mohammed Majrashi has collaborated with scholars based in Saudi Arabia, United States and Egypt. Frequent co-authors include Muralikrishnan Dhanasekaran, Sindhu Ramesh, Manoj Govindarajulu, Vishnu Suppiramaniam, Timothy Moore, Dwipayan Bhattacharya, Rajesh Amin, Mohammed Alissa, Mohammed Almaghrabi and Manal Buabeid. Their work appears in journals such as PLoS ONE, The FASEB Journal and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.